carbon monoxide has been researched along with Bilirubinemia in 27 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The main aims were to inspect the erythrocyte (RBC) survival in GS by using Levitt's carbon monoxide (CO) breath test and to assess its contribution to unconjugated hyperbilirubinemia." | 9.34 | Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome. ( Kang, LL; Ma, YJ; Zhang, HD, 2020) |
| "The predominant cause of elevated total/plasma bilirubin (TB) levels is from an increase in bilirubin production primarily because of ongoing hemolysis." | 9.12 | Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production. ( Bao, Y; Bhutani, VK; Chen, L; Du, L; Ma, X; Shen, X, 2021) |
| " Routine management included measurement of the end tidal carbon monoxide level corrected for ambient carbon monoxide level (ETCOc) within 4 hours after delivery (assessment of hemolysis), > or =1 predischarge bilirubin determination, and additional bilirubin testing as clinically indicated." | 7.72 | Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. ( Hammerman, C; Herschel, M; Hoyer, JD; Kaplan, M; Stevenson, DK, 2004) |
| "The purpose of this study was to determine whether end-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc), as a single measurement or in combination with serum total bilirubin (STB) measurements, can predict the development of hyperbilirubinemia during the first 7 days of life." | 7.71 | Prediction of hyperbilirubinemia in near-term and term infants. ( Bhutani, VK; Fanaroff, AA; Gale, R; Hammerman, C; Johnson, LH; Kaplan, M; MacMahon, JR; Maisels, MJ; Nakamura, H; Oh, W; Seidman, DS; Stevenson, DK; Vreman, HJ; Wong, RJ; Yeung, CY; Young, BW, 2001) |
| "Pulmonary carbon monoxide (CO) excretion rates (VeCO) were 50% greater, on average, in Bolivian squirrel monkeys (BoSMs) which exhibit a unique fasting hyperbilirubinemia (FH), than in fasted control Brazilian squirrel monkeys (BrSMs)." | 7.68 | Increased carbon monoxide excretion in Bolivian squirrel monkeys with fasting hyperbilirubinemia. ( Cornelius, CE; Rodgers, PA; Tarkington, BK; Vreman, HJ, 1990) |
| "Hyperbilirubinemia is a condition of major importance and a source of concern to all involved in the management of the newborn." | 6.43 | Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. ( Hammerman, C; Kaplan, M, 2005) |
| "When hemolysis is identified, parents are likely to comply with instructions to bring the infant for a TB checkup <24 h after discharge home." | 5.43 | Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis. ( Baer, VL; Christensen, RD; Denson, LE; Gerday, E; Lambert, DK; Malleske, DT; Prchal, JT; Shepherd, JG; Weaver Lewis, KA, 2016) |
| " Before the recent development of practical and inexpensive testing for hemolysis by quantifying carbon monoxide in end-tidal breath, some hemolytic disorders in perinatal patients were not detected until severely problematic hyperbilirubinemia and/or anemia occurred." | 5.41 | Perinatal Hemolytic Disorders and Identification Using End Tidal Breath Carbon Monoxide. ( Bahr, TM; Christensen, RD; Pakdeeto, S; Supapannachart, S; Zhang, H, 2023) |
| " The main aims were to inspect the erythrocyte (RBC) survival in GS by using Levitt's carbon monoxide (CO) breath test and to assess its contribution to unconjugated hyperbilirubinemia." | 5.34 | Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome. ( Kang, LL; Ma, YJ; Zhang, HD, 2020) |
| "The predominant cause of elevated total/plasma bilirubin (TB) levels is from an increase in bilirubin production primarily because of ongoing hemolysis." | 5.12 | Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production. ( Bao, Y; Bhutani, VK; Chen, L; Du, L; Ma, X; Shen, X, 2021) |
| "To establish a reference nomogram for end-tidal CO corrected for ambient CO (ETCOc) levels in term and late-preterm Chinese newborns and then assess its efficacy to identify hemolytic hyperbilirubinemia." | 4.12 | An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns. ( Bao, Y; Du, L; He, Y; Ma, L; Sun, L; Wu, J; Xu, C; Zhang, H; Zhu, J, 2022) |
| " The use of tin mesoporphyrin (SnMP) has been proposed for interdicting the development of severe hyperbilirubinemia in a variety of conditions." | 3.73 | The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model. ( Contag, CH; DeSandre, GH; Morioka, I; Stevenson, DK; Wong, RJ, 2006) |
| " Routine management included measurement of the end tidal carbon monoxide level corrected for ambient carbon monoxide level (ETCOc) within 4 hours after delivery (assessment of hemolysis), > or =1 predischarge bilirubin determination, and additional bilirubin testing as clinically indicated." | 3.72 | Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. ( Hammerman, C; Herschel, M; Hoyer, JD; Kaplan, M; Stevenson, DK, 2004) |
| "The purpose of this study was to determine whether end-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc), as a single measurement or in combination with serum total bilirubin (STB) measurements, can predict the development of hyperbilirubinemia during the first 7 days of life." | 3.71 | Prediction of hyperbilirubinemia in near-term and term infants. ( Bhutani, VK; Fanaroff, AA; Gale, R; Hammerman, C; Johnson, LH; Kaplan, M; MacMahon, JR; Maisels, MJ; Nakamura, H; Oh, W; Seidman, DS; Stevenson, DK; Vreman, HJ; Wong, RJ; Yeung, CY; Young, BW, 2001) |
| "Pulmonary carbon monoxide (CO) excretion rates (VeCO) were 50% greater, on average, in Bolivian squirrel monkeys (BoSMs) which exhibit a unique fasting hyperbilirubinemia (FH), than in fasted control Brazilian squirrel monkeys (BrSMs)." | 3.68 | Increased carbon monoxide excretion in Bolivian squirrel monkeys with fasting hyperbilirubinemia. ( Cornelius, CE; Rodgers, PA; Tarkington, BK; Vreman, HJ, 1990) |
| "The role of increased heme catabolism in neonatal hyperbilirubinemia was investigated in rhesus (Macaca mulatta) neonates through the measurement of carbon monoxide excretion rates (VECO), blood carboxyhemoglobin content (HbCO), and plasma bilirubin concentrations." | 3.67 | Carbon monoxide excretion as an index of bilirubin production in rhesus monkeys. ( Gale, R; Rodgers, PA; Stevenson, DK; Vreman, HJ, 1989) |
| "Hyperbilirubinemia is a condition of major importance and a source of concern to all involved in the management of the newborn." | 2.43 | Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. ( Hammerman, C; Kaplan, M, 2005) |
| "When hemolysis is identified, parents are likely to comply with instructions to bring the infant for a TB checkup <24 h after discharge home." | 1.43 | Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis. ( Baer, VL; Christensen, RD; Denson, LE; Gerday, E; Lambert, DK; Malleske, DT; Prchal, JT; Shepherd, JG; Weaver Lewis, KA, 2016) |
| "To facilitate comparison, hyperbilirubinemia was induced through a 36-hr period of subtotal caloric restriction before the study." | 1.26 | Glucose administration and heme catabolism after caloric restriction. ( Lundh, B; Ugander, L, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (37.04) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y | 2 |
| Zhu, J | 1 |
| Ma, L | 1 |
| Zhang, H | 2 |
| Sun, L | 1 |
| Xu, C | 1 |
| Wu, J | 1 |
| He, Y | 1 |
| Du, L | 2 |
| Christensen, RD | 2 |
| Bahr, TM | 1 |
| Pakdeeto, S | 1 |
| Supapannachart, S | 1 |
| Kang, LL | 1 |
| Ma, YJ | 1 |
| Zhang, HD | 1 |
| Elsaie, AL | 1 |
| Taleb, M | 1 |
| Nicosia, A | 1 |
| Zangaladze, A | 1 |
| Pease, ME | 1 |
| Newton, K | 1 |
| Schutzman, DL | 1 |
| Ma, X | 1 |
| Shen, X | 1 |
| Chen, L | 1 |
| Bhutani, VK | 3 |
| Wong, RJ | 3 |
| Vreman, HJ | 6 |
| Stevenson, DK | 8 |
| Malleske, DT | 1 |
| Lambert, DK | 1 |
| Baer, VL | 1 |
| Prchal, JT | 1 |
| Denson, LE | 1 |
| Gerday, E | 1 |
| Weaver Lewis, KA | 1 |
| Shepherd, JG | 1 |
| FLAUTO, U | 1 |
| BONCOMPAGNI, P | 1 |
| MARINI, A | 1 |
| Kaplan, M | 4 |
| Herschel, M | 1 |
| Hammerman, C | 4 |
| Hoyer, JD | 1 |
| DeSandre, GH | 1 |
| Morioka, I | 1 |
| Contag, CH | 1 |
| Wranne, L | 1 |
| Marks, GS | 1 |
| Leiter, C | 1 |
| Abramov, A | 1 |
| Labbé, RF | 1 |
| Schüller Pérez, A | 1 |
| Fanaroff, AA | 1 |
| Maisels, MJ | 2 |
| Young, BW | 1 |
| MacMahon, JR | 1 |
| Yeung, CY | 1 |
| Seidman, DS | 1 |
| Gale, R | 2 |
| Oh, W | 1 |
| Johnson, LH | 1 |
| Nakamura, H | 1 |
| Valaes, T | 1 |
| Bartoletti, AL | 1 |
| Ostrander, CR | 1 |
| Johnson, JD | 1 |
| Lundh, B | 1 |
| Ugander, L | 1 |
| Rodgers, PA | 2 |
| Cornelius, CE | 1 |
| Tarkington, BK | 1 |
| Robinson, SH | 1 |
| Pathak, A | 1 |
| Nelson, NM | 1 |
| Kandall, SR | 1 |
| Landaw, SA | 1 |
| Thaler, MM | 1 |
| Fällström, SP | 1 |
| Bjure, J | 1 |
| Bloomer, JR | 1 |
| Barrett, PV | 1 |
| Rodkey, FL | 1 |
| Berlin, NI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Value of ETCOc in the Diagnosis and Treatment of ABO Hemolytic Disease of the Newborn[NCT05842109] | 112 participants (Anticipated) | Observational | 2023-05-01 | Not yet recruiting | |||
| End Tidal Carbon Monoxide (ETCO) : A Tool to Aid Identification of Neonatal Hemolysis[NCT05475223] | 350 participants (Anticipated) | Interventional | 2022-07-29 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for carbon monoxide and Bilirubinemia
| Article | Year |
|---|---|
Perinatal Hemolytic Disorders and Identification Using End Tidal Breath Carbon Monoxide.
Topics: Carbon Monoxide; Cell Death; Female; Hemolysis; Humans; Hyperbilirubinemia; Infant, Newborn; Infant, | 2023 |
Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.
Topics: Bilirubin; Carbon Monoxide; Hemolysis; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Neonatal; Inf | 2021 |
Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin.
Topics: Bilirubin; Blood Group Incompatibility; Carbon Monoxide; Hemolysis; Humans; Hyperbilirubinemia; Infa | 2005 |
Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins.
Topics: Animals; Carbon Monoxide; Heme Oxygenase (Decyclizing); Humans; Hyperbilirubinemia; Long-Term Potent | 1994 |
Zinc protoporphyrin: A metabolite with a mission.
Topics: Anemia, Iron-Deficiency; Animals; Animals, Newborn; Bilirubin; Carbon Monoxide; Erythrocytes; Heme; | 1999 |
[The heme oxygenase system and its physiopathology].
Topics: Biliverdine; Carbon Monoxide; Heme; Heme Oxygenase (Decyclizing); Humans; Hyperbilirubinemia; Iron; | 1999 |
Formation of bilirubin from erythroid and nonerythroid sources.
Topics: Anemia, Aplastic; Animals; Bile Pigments; Bilirubin; Blood Transfusion; Carbon Isotopes; Carbon Mono | 1972 |
1 trial available for carbon monoxide and Bilirubinemia
| Article | Year |
|---|---|
Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome.
Topics: Adult; Breath Tests; Carbon Monoxide; Erythrocytes; Female; Gilbert Disease; Hemolysis; Humans; Hype | 2020 |
19 other studies available for carbon monoxide and Bilirubinemia
| Article | Year |
|---|---|
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.
Topics: Bilirubin; Carbon Monoxide; China; Hemolysis; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Neonat | 2022 |
Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia.
Topics: Bilirubin; Carbon Monoxide; Child; Coombs Test; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Neon | 2020 |
Bilirubin production and hour-specific bilirubin levels.
Topics: Bilirubin; Carbon Monoxide; Female; Gestational Age; Humans; Hyperbilirubinemia; Infant, Newborn; In | 2015 |
Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.
Topics: Bilirubin; Birthing Centers; Breath Tests; Carbon Monoxide; Female; Hematologic Tests; Heme; Hemolys | 2016 |
[BEHAVIOR OF CARBOXYHEMOGLOBIN IN HEMOLYTIC DISEASE OF THE NEWBORN].
Topics: ABO Blood-Group System; Carbon Monoxide; Carboxyhemoglobin; Erythroblastosis, Fetal; Fetus; Hemoglob | 1964 |
Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.
Topics: Bilirubin; Black People; Carbon Monoxide; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydroge | 2004 |
The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model.
Topics: Animals; Bilirubin; Carbon Monoxide; Disease Models, Animal; Heme; Heme Oxygenase-1; Hyperbilirubine | 2006 |
Studies on erythro-kinetics in infancy. VII. Quantitative estimation of the haemoglobin catabolism by carbon monoxide technique in young infants.
Topics: Air; Bilirubin; Blood Group Incompatibility; Carbon Monoxide; Erythrocyte Aging; Erythrocytes; Femal | 1967 |
Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates.
Topics: Carbon Monoxide; Carboxyhemoglobin; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Hy | 1996 |
Prediction of hyperbilirubinemia in near-term and term infants.
Topics: Bilirubin; Carbon Monoxide; Female; Gestational Age; Humans; Hyperbilirubinemia; Infant, Newborn; Ma | 2001 |
Problems with prediction of neonatal hyperbilirubinemia.
Topics: Bilirubin; Carbon Monoxide; Evidence-Based Medicine; Humans; Hyperbilirubinemia; Infant, Newborn; Mu | 2001 |
Pulmonary excretion of carbon monoxide in the human newborn infant as an index of bilirubin production: III. Measurement of pulmonary excretion of carbon monoxide after the first postnatal week in premature infants.
Topics: Bilirubin; Carbon Monoxide; Erythrocyte Aging; Gestational Age; Humans; Hyperbilirubinemia; Infant, | 1979 |
Glucose administration and heme catabolism after caloric restriction.
Topics: Administration, Oral; Adult; Bilirubin; Carbon Monoxide; Diet; Energy Intake; Glucose; Heme; Humans; | 1976 |
Increased carbon monoxide excretion in Bolivian squirrel monkeys with fasting hyperbilirubinemia.
Topics: Animals; Bilirubin; Bolivia; Brazil; Carbon Monoxide; Disease Models, Animal; Fasting; Gilbert Disea | 1990 |
Carbon monoxide excretion as an index of bilirubin production in rhesus monkeys.
Topics: Animals; Animals, Newborn; Bilirubin; Carbon Monoxide; Carboxyhemoglobin; Disease Models, Animal; He | 1989 |
The effect of exchange transfusion on endogenous carbon monoxide production in erythroblastotic infants.
Topics: Bilirubin; Body Weight; Carbon Monoxide; Chromatography, Gas; Erythroblastosis, Fetal; Exchange Tran | 1972 |
Carboxyhemoglobin exchange between donors and recipients of blood transfusions.
Topics: Birth Weight; Blood Donors; Blood Gas Analysis; Carbon Monoxide; Carboxyhemoglobin; Chromatography, | 1973 |
Endogenous formation of carbon monoxide in newborn infants. II. Rh haemolytic disease of the newborn.
Topics: Carbon Monoxide; Erythroblastosis, Fetal; Erythrocytes; Exchange Transfusion, Whole Blood; Female; H | 1967 |
Studies on the mechanism of fasting hyperbilirubinemia.
Topics: Animals; Bilirubin; Body Weight; Carbon Monoxide; Fasting; Humans; Hyperbilirubinemia; Hyperbilirubi | 1971 |